Documents

A list of downloadable documents created during development.

Expected publication

Final appraisal determination: 2

Appraisal consultation: 2

Appraisal consultation

Prostate cancer (metastatic, castrate-resistant, not treated with chemotherapy) - abiraterone acetate (with prednisolone): letter to consultees about suspension of appraisal

Prostate cancer (metastatic, castrate-resistant, not treated with chemotherapy) - abiraterone acetate (with prednisolone): Appendix B - final scope

Prostate cancer (metastatic, castrate-resistant, not treated with chemotherapy) - abiraterone acetate (with prednisolone): Appendix C - final matrix

Prostate cancer (metastatic, castrate-resistant, not treated with chemotherapy) - abiraterone acetate (with prednisolone): Appendix D - response to comments on the draft scope and provisional matrix

Prostate cancer (metastatic, castrate-resistant, not treated with chemotherapy) - abiraterone acetate (with prednisolone): EIA form - scoping

Appendix B - draft scope for consultation (pre-referral) - July 2011

Appendix C - provisional matrix (pre-referral) - July 2011